Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Abliva

Less than 1K followers
All
Webcasts
Press releases
3rd party
ShowingAll content types
Press release3/17/2025, 11:05 AM

BioStock: Last trading day for Abliva - the company leaves Nasdaq Stockholm

Abliva
Regulatory press release3/3/2025, 12:10 PM

Delisting of the shares of Abliva: last day of trading 17 March 2025

Abliva
Regulatory press release2/26/2025, 7:30 AM

Notice of Extraordinary General Meeting in Abliva AB (publ)

Abliva

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2/25/2025, 8:50 AM

Abliva applies for delisting and will convene an extraordinary general meeting

Abliva
Regulatory press release2/21/2025, 7:30 AM

Abliva AB Year-End Report January – December 2024

Abliva
Press release2/10/2025, 9:43 AM

BioStock: Pharming completes bid for Abliva

Abliva
Regulatory press release12/15/2024, 7:00 PM

Statement by the Board of Directors of Abliva regarding the public cash offer from Pharming

Abliva
Press release12/9/2024, 7:32 AM

Abliva Announces Publication of Results from Phase 1a/b Study of KL1333 in the Scientific Journal Brain

Abliva
Press release12/4/2024, 10:34 AM

BioStock: From mutation to solution - Abliva gains ground

Abliva
Regulatory press release11/29/2024, 5:00 PM

Abliva AB Interim Report January – September 2024

Abliva
Press release11/4/2024, 10:00 AM

Abliva will present at the BioStock Life Science Summit, November 21

Abliva
Press release9/18/2024, 7:38 AM

BioStock: Abliva leads the fight against mitochondrial disease

Abliva
Press release9/16/2024, 6:30 AM

Join Abliva for World Mitochondrial Disease Week 2024, September 16 – 22

Abliva
Regulatory press release8/30/2024, 6:30 AM

Amended number of shares and votes in Abliva AB (publ)

Abliva
Press release8/26/2024, 6:46 AM

BioStock: Abliva's CEO - We are the leading programme in mitochondrial disease

Abliva
Regulatory press release8/22/2024, 6:30 AM

Abliva AB Interim Report January – June 2024

Abliva
Press release7/24/2024, 9:57 AM

Abliva's CEO to BioStock: "One step closer to a marketed medicine"

Abliva
Regulatory press release7/19/2024, 6:30 AM

Positive interim analysis in Abliva's FALCON study triggers convertible loan conversion

Abliva
Regulatory press release7/18/2024, 8:22 PM

Abliva Announces Positive Interim Analysis of the FALCON Study for KL1333 in Primary Mitochondrial Disease

Abliva
Regulatory press release5/31/2024, 6:30 AM

Amended number of shares and votes in Abliva AB (publ)

Abliva
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.